Back to Newsroom

Cempra, Inc. to Present at JMP Securities Healthcare Conference

CHAPEL HILL, N.C., June 17, 2014 (GLOBE NEWSWIRE) — Cempra, Inc. (Nasdaq:CEMP) today announced that Prabhavathi Fernandes, Ph.D., chief executive officer of Cempra, will present at the JMP Securities Healthcare Conference at 10:30 a.m. EDT, Tuesday, June 24, at The Westin New York Grand Central in New York City. Dr. Fernandes will discuss the company’s two differentiated antibiotics, solithromycin (CEM-101) for community-acquired bacterial pneumonia and gonorrhea and Taksta™ (CEM-102 or fusidic acid) for oral treatment of chronic staphyloccoal infection including methicillin-resistant S. aureus (MRSA) in prosthetic joint infections.

Click here to read more